ICOS/B7RP-1 interference in mouse kidney transplantation

Area of Science:

• Immunology
• Transplantation Biology

Background:

• T cell activation is crucial for allograft rejection, involving T cell receptor signaling and costimulatory signals.
• Inducible Costimulatory Molecule (ICOS) and its ligand B7RP-1 are key CD28 family costimulatory molecules.
• The role of the ICOS-B7RP-1 pathway in early kidney allograft rejection remains unclear.

Purpose of the Study:

• To investigate the role of the ICOS-B7RP-1 signaling pathway in early kidney allograft rejection.
• To determine the effects of blocking ICOS or B7RP-1 on T cell apoptosis and graft survival.

Main Methods:

• Orthotopic kidney transplantation from BALB/c to C57BL/6 mice.
• Treatment groups included blocking anti-ICOS monoclonal antibody (mAb), ICOS fusion protein, anti-B7RP-1 mAb, B7RP-1 fusion protein, and control immunoglobulin G.
• Graft survival, T cell apoptosis, and interferon-gamma expression were assessed.

Main Results:

• Blocking ICOS with anti-ICOS mAb or B7RP-1 with B7RP-1 Fc significantly reduced graft survival.
• These blocking treatments led to decreased apoptotic graft-infiltrating T cells and increased intracellular interferon-gamma in CD3CD4 T cells.
• Conversely, ICOS Fc and B7RP-1 mAb treatments showed similar survival and apoptosis rates as controls.

Conclusions:

• Blockade of ICOS signaling via ICOS mAb or B7RP-1 Fc inhibits T cell apoptosis during kidney allograft rejection.
• This inhibition promotes sustained inflammatory processes, leading to progressive tissue damage and graft failure.
• Targeting the ICOS pathway requires careful consideration due to its complex role in immune responses and allograft outcomes.